The treatment of symptomatic hyponatremia with hypertonic saline in an ironman triathlete

Clinical Journal of Sport Medicine

Volumn 17, Issue 1, 2007, Pages 68-69

  Hew Butler, Tamara ^a   Anley, Cameron ^a   Schwartz, Peter ^b   Noakes, Timothy ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b South African Ironman Triathlon ^*  (South Africa)

Author keywords

Hypertonic saline; Hyponatremia; Triathlete

Indexed keywords

METOCLOPRAMIDE; SODIUM CHLORIDE;

ADULT; ARTICLE; ATHLETE; CASE REPORT; DELUSION; DIARRHEA; HUMAN; HYPONATREMIA; MALE; MENTAL HEALTH; NAUSEA; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; STENT; TRIATHLON;

ADULT; ATHLETIC INJURIES; EXERTION; HUMANS; HYPONATREMIA; MALE; PHYSICAL ENDURANCE; SALINE SOLUTION, HYPERTONIC; SPORTS; WATER-ELECTROLYTE IMBALANCE;

EID: 33847157529     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e31802e9c18     Document Type: Article

References (8)

1. Hew-Butler TD, Almond CS, Ayus JC, et al. Consensus Statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clin J Sport Med. 2005;15:208-213.
2. Ayus JC, Arieff A, Moritz ML. Hyponatremia in marathon runners. N Engl J Med. 2005;353:427-428.
3. Speedy DB, Noakes TD, Rogers IR, et al. Hyponatremia in ultradistance triathletes. Med Sci Sports Exerc. 1999;31:809-815.
4. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:471-503.
5. Wharam PC, Speedy DB, Noakes TD, et al. NSAID use increases the risk of developing hyponatremia during an Ironman triathlon. Med Sci Sports Exerc. 2006;38:618-622.
6. Speedy DB, Noakes TD, Kimber NE, et al. Fluid balance during and after an Ironman triathlon. Clin J Sport Med. 2001;11:44-50.
7. Shafiee MA, Charest AF, Cheema-Dhadli S, et al. Defining conditions that lead to the retention of water: the importance of the arterial sodium concentration. Kidney Int. 2005;67:613-621.
8. Worthley LIG, Thomas PD. Treatment of hyponatremic seizures with intravenous 29.2% saline. BMJ. 1986;292:168-170.